Fluoxetine EC Pellets Manufacturer in India

Fluoxetine EC Pellets Manufacturer in India

Pharmaceutical-Grade Fluoxetine EC Pellets for Enteric-Coated Oral Formulations

Fluoxetine EC Pellets are multiparticulate pharmaceutical formulations designed for enteric-coated oral dosage applications. The active ingredient is Fluoxetine Hydrochloride, identified by CAS Number 56296-78-7, molecular formula C₁₇H₁₉ClF₃NO, and molecular weight 345.79 g/mol. These chemical details are supported by USP reference-standard information and chemical databases.

Fluoxetine EC Pellets are available in 35% and 50% strengths in established pharmaceutical pellet product portfolios.

The enteric-coated pellet format uses a functional coating system to modify the release characteristics of the multiparticulate formulation. Published patent literature describes enteric-coated Fluoxetine formulations using methacrylic-acid-based coating polymers, demonstrating the technical basis for enteric coating of Fluoxetine multiparticulates.

Key Features

• Fluoxetine Hydrochloride enteric-coated pharmaceutical pellets
• Available in 35% and 50% strengths
• Pharmaceutical-grade multiparticulate formulation
• Enteric-coated formulation platform
• Functional coating for modified release characteristics
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Multiple active-loading options
• Product-specific quality parameters
• Formulation flexibility for pharmaceutical manufacturers
• Suitable for bulk pharmaceutical requirements

Product Information

Fluoxetine Hydrochloride is the hydrochloride salt of Fluoxetine. The standard material is identified by CAS 56296-78-7, with molecular formula C₁₇H₁₉ClF₃NO and molecular weight 345.79 g/mol.

Fluoxetine Hydrochloride is a racemic material containing both enantiomeric forms. The CAS number 56296-78-7 should therefore be used for the standard Fluoxetine Hydrochloride material rather than the CAS numbers assigned to individual enantiomers.

For the finished pellet product, the 35% and 50% values represent active ingredient loading and should not be interpreted as the purity assay of the Fluoxetine Hydrochloride raw material.

Available Strengths

• Fluoxetine EC Pellets — 35%
• Fluoxetine EC Pellets — 50%

These strengths are consistently reported in multiple Indian pharmaceutical pellet product portfolios.

Applications

Fluoxetine EC Pellets can be considered for:

• Enteric-coated oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Modified-release formulation development
• Functional-coated pellet systems
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Fluoxetine EC Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 35% and 50% Strength Options: Provides flexibility in active ingredient loading.
• Enteric-Coated Format: Designed for formulations requiring an enteric-coated multiparticulate platform.
• Multiparticulate Formulation: Suitable for pellet-based oral dosage-form development.
• Functional Coating Technology: Enteric coating can be used to modify release according to the intended formulation profile.
• Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
• Capsule-Filling Applications: Suitable for multiparticulate capsule formulation approaches.
• Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Fluoxetine EC Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp